DIBIASE MARY (Chief Operating Officer) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/2/2023ACC: 0001628280-23-036459
Officer· Chief Operating Officer
Since Sep 2021
+230.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
230.65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+230.65K
Price / share
—
Trade value
—
% of position
156.0%
10/31/2023
147.89K→378.54K
Total
Net shares
+230.65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2023 | A · Award | +230.65K | — | — | 156.0% | 147.89K | 378.54K |
| Total | +230.65K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported